Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

VIVUS Inc. (VVUS)

-NasdaqGS
2.42 0.00(0.00%) Apr 17, 4:00PM EDT
|After Hours : 2.42 0.00 (0.00%) Apr 17, 7:38PM EDT
Add to Portfolio
Prev Close:2.42
Open:2.40
Bid:2.11 x 200
Ask:2.42 x 1000
1y Target Est:4.00
Beta:1.06
Earnings Date:May 4 - May 8 (Est.)
Day's Range:2.36 - 2.45
52wk Range:2.28 - 5.95
Volume:978,037
Avg Vol (3m):2,255,420
Market Cap:251.39M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUS 0.00%251.39M
LLYDown 1.39%76.86B
GSKDown 0.61%113.76B
PFEDown 0.43%214.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.13
Quarterly EPS Est (Mar-15) :-0.22
Mean Recommendation*:3.3
PEG Ratio (5 yr expected):-0.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback